Immune Deficiency-Associated Lymphoma
A Special Issue of Cancers (ISSN 2072-6694) belonging to the section "Cancer Immunology and Immunotherapy".
Deadline for manuscript submissions: closed (25 June 2026) | Viewed by 1205
Editor
Interests: acute leukemia; tumor escape; natural killer cells; chemotherapy; single cell analysis; CRISPR cas9
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Lymphomas occurring in patients with immunodeficiency have specific characteristics in terms of their presentation, pathological diagnosis, pathophysiology, and therapeutic management. They occur in very different circumstances: associated with human immunodeficiency virus infection, in organ or hematopoietic stem cell transplant patients, in the context of genetic immunodeficiency syndromes, or associated with immunosuppressive therapies for systemic diseases. Where possible, improving the immune response (reducing immunosuppressants, controlling HIV infection) is an important part of treatment, usually associated with an immuno-chemotherapy approach. These different aspects will be discussed in this Special Issue.
Prof. Dr. Régis Thierry Costello
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lymphoma
- immune
- HIV infection
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
